Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Plasma cell 1Classical hematology 1

Conditions

Multiple Myeloma 1086Neoplasms, Plasma Cell 255Lymphoma 157Lymphoma, Non-Hodgkin 150Hodgkin Disease 135Recurrence 130Leukemia, Lymphocytic, Chronic, B-Cell 130Precursor Cell Lymphoblastic Leukemia-Lymphoma 116Myelodysplastic Syndromes 111Leukemia 109Leukemia, Myeloid, Acute 106Lymphoma, Follicular 84Lymphoma, Mantle-Cell 83Lymphoma, B-Cell, Marginal Zone 82Burkitt Lymphoma 76Lymphoma, Large B-Cell, Diffuse 74Myeloproliferative Disorders 70Immunoglobulin Light-chain Amyloidosis 67Lymphoma, Large-Cell, Immunoblastic 65Hematologic Neoplasms 63Primary Myelofibrosis 58Leukemia, Myeloid, Chronic-Phase 57Leukemia, Myeloid, Accelerated Phase 51Leukemia, Myelogenous, Chronic, BCR-ABL Positive 49Waldenstrom Macroglobulinemia 46Blast Crisis 44Congenital Abnormalities 43Leukemia, Myelomonocytic, Chronic 42Dendritic Cell Sarcoma, Interdigitating 42Smoldering Multiple Myeloma 41

Interventions

Hizentra 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Agammaglobulinemia × Plasma cell × Clear all
NCT06976476 2026-03-11

Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
100 enrolled
Plasma cell

Agammaglobulinemia, Multiple Myeloma, Common Variable Immunodeficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡